TRIM33 monoubiquitinates SMAD4, inhibiting the formation of SMAD transcriptional complexes, and thereby suppresses TGF-β/SMAD signaling which contributes to invasion and metastasis in HCC cells [145]. The gene discussed is TRIM33; the disease is hepatocellular carcinoma.